ELMMB logo
Facebook logo Twitter logo
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 4th January 2022      MHRA Press Release Strong Steroid found in 'natural' skin cream. MHRA have issued a recall asking patients
                                     to return affected products.
11th Nov 2021           News Release Patient safety priority in recall of batches of cold and flu medicine with labelling error.
15th Sept 2021          MHRA Press Release The MHRA is advising anyone experiencing skin redness or burning sensations after
                                     they have stopped using these creams or ointments to seek advice from their health professional before
                                     using these products again.
 9th August 2021       MHRA Press Release MHRA recalls contaminated Irbesartan-batches as a precautionary measure. 
                                                                        Patients should not stop any treatments without consulting their doctor or pharmacist.
 8th July 2021             MHRA Press Release First progesterone-only contraceptive pills to be available to purchase from pharmacies      
 1st July 2021             Company led medicines recall: Morphine Syringe 50mg/50ml [unlicensed medicine] and Magnesium Sulphate
                                                                                         8mmol/20ml infusion [unlicensed medicine]
 17th June 2021         MHRA Press Release  MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
 8th June 2021           MHRA Press Release  Over 3 million medicines and devices seized in UK as part of global crackdown
 28th May 2021         MHRA Press Release A personal trainer sentenced to 31 months in jail for selling and supplying unlicensed and                                                                                prescription medicines, together with Anabolic steroids, to the public.        
 4th May 2021           MHRA Press Release  MHRA announces appointment of Chief Safety Officer

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

application/pdfDiamorphine Hcl BP 100mg lyophilisate for soln for inj Cl 4 meds defect info 0220_Final.pdf (138KB)17/02/2020Download
 Accord Healthcare Ltd has informed us of an issue related to the expiry date for the batches in this alert, which has not been encoded in 2D data matrix. Upon FMD scanning verification and... 
application/pdfAtrolak XL 50mg PL tabs Cl4 meds recakk EL__20_A_06_Final 0220.pdf (90KB)12/02/2020Download
 Accord Healthcare Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the above batches is missing the side effects identified from post-marketing experience that are... 
application/pdfFinasteride_meds defect information EL__20_A_030120.pdf (107KB)29/01/2020Download
 Dr. Reddy's Laboratories (UK) Ltd has informed us that the Patient Information Leaflet (PIL) for the above batches is missing the special warning and precautions identified from post-marketing... 
application/pdfPicato 150mcg per g gel Class 2 medicines recall 270120.pdf (196KB)27/01/2020Download
 LEO Laboratories Ltd (T/A LEO Pharma) is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to concerns on the possible risk of skin... 
application/pdfRanitidine 150mg 300mg tablets Medley Pharma EL__19_A_41_Final.pdf (100KB)17/12/2019Download
 Medley Pharma Limited is recalling all unexpired stock of the above products from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity... 
application/pdfMetformin EMA Update_diabetes-medicines_en121219.pdf (126KB)12/12/2019Download
 EMA update on metformin diabetes medicines: EMA is aware that trace amounts of an impurity, N-nitrosodimethylamine (NDMA), have been found in a small number of metformin diabetes medicines outside... 
application/pdfRanitidine 150mg 300mg Class 3 meds recall Accord 051219_Final_2.pdf (99KB)05/12/2019Download
 ranitidine, accord, medicines, recall, drug,safety, dsu 
application/pdfDrug Safety Update July 19 Febuxostat.pdf (159KB)02/12/2019Download
 Increased risk of cardiovascular death and all-cause mortality in clinical trials in patients with a history of major cardiovascular disease 
application/pdfEmerade 150_300_and_500_microgram_solution_for_injection pfs Class_2_Medicines_Recall_Emerade_281119 (250KB)29/11/2019Download
 Pharmaswiss ńĆeska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of the above product due an error in one component of the autoinjector believed to... 
application/pdfRanit oral 30mgml 150mg tabs Class 2 meds recall_EL__19_A_36_Final (1).pdf (123KB)20/11/2019Download
application/pdfFolic Acid 5mg tabs_accord_UK_ Cl3 meds recall_EL__19_A_35_Final.pdf (108KB)19/11/2019Download
 Accord-UK Ltd has informed us of an issue related to decommissioning of the above batch. Upon decommissioning at the pharmacy, there have been reports stating that when scanning the serialised 2D... 
application/pdfSayana Press Class 2 Medicines recall Sayana Press Oct 19.pdf (138KB)23/10/2019Download
 Pfizer Ltd has informed us of an issue related to the sealing process for some units of Sayana Press for subcutaneous (SC) injection potentially impacting the above listed batches. Sayana Press for... 
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]